Efficacy and Safety of Loxapine in Acute Agitation: A Systematic Review of Interventional Studies.
The primary care companion for CNS disorders · 2023-12-19 · Systematic review
Abstract
Objective: To assess the efficacy and safety of loxapine in acute agitation. Data Sources: PubMed, Cochrane database, EMBASE, PsycINFO, and ClinicalTrials.gov were searched to identify relevant articles published in English or French from inception to March 15, 2022. The term "Loxap*" was searched in titles and abstracts. Study Selection and Data Extraction: Interventional studies that compared the effectiveness of loxapine to any other intervention (including another administration route or dosage of loxapine, other drugs, and placebo) in acute agitation were included. From the 1,435 articles initially identified, and after the assessment of 73 full texts, 7 articles were selected, encompassing 1,276 participants. Two reviewers independently extracted data of interest using a predefined form. Results: Among included studies, 5 were double-blind, 2 were open-label, and all were randomized. The risk of bias was low for 2 studies, involving 658 participants. Four articles compared loxapine to placebo, and 3 compared it with haloperidol, aripiprazole, and droperidol. Loxapine was found to be more effective and faster regarding acute agitation control. Also, across included studies, loxapine was well-tolerated, with mildly or moderately severe adverse effects. Conclusions: Notwithstanding methodological limitations of the included studies, this systematic review provides reassuring results regarding the use of loxapine in acute agitation. However, further studies with methodological optimizations might be of interest. Prim Care Companion CNS Disord 2023;25(6):23r03552. Author affiliations are listed at the end of this article.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Sedatives & anxiolytics · Antipsychotics
Related articles
- Efficacy and safety of intramuscular and intravenous midazolam for acute agitation in emergency settings: a systematic review. (Int Clin Psychopharmacol, 2026)
- Prehospital management of acute behavioural disturbance: managing severe agitation in the prehospital setting - a systematic literature review. (Emerg Med J, 2026)
- Comparative Safety of Medications for Severe Agitation: A Geriatric Emergency Department Guidelines 2.0 Systematic Review. (J Am Geriatr Soc, 2025)
- Agitation management strategies for older adults in the emergency department or with emergency medical services: A scoping review. (Am J Emerg Med, 2025)
- "Pharmacological management of acute agitation in psychiatric patients: an umbrella review". (BMC Psychiatry, 2025)
- A systematic review of the effectiveness and safety of droperidol for pediatric agitation in acute care settings. (Acad Emerg Med, 2022)